Clinical Trial Update: Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy volunteers evaluated whether a single 150 mg risedronate tablet is bioequivalent to two 75 mg tablets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Actonel (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED